发明名称 Cell populations which co-express CD49C and CD90
摘要 <p>Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made by selecting from a cultured source of a cell population which co-expresses CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition and to formulate pharmaceutical compositions. In a further embodiment, a substantially homogenous populaton of cells which co-express CD49c, CD90 and at least one cardiac-related transcription factor is made and can be used to treat a human suffering from a cardiac condition.</p>
申请公布号 AU2009208096(B2) 申请公布日期 2013.01.24
申请号 AU20090208096 申请日期 2009.08.11
申请人 GARNET BIOTHERAPEUTICS, INC. 发明人 HO, TONY W.;KOPEN, GENE C.;RIGHTER, WILLIAM F.;RUTKOWSKI, J. LYNN;HERRING, W. JOSEPH;RAGAGLIA, VANESSA;WAGNER, JOSEPH
分类号 C12N15/09;A61K35/12;A61K35/28;A61K35/34;A61K35/36;A61K35/44;A61K35/50;A61P9/04;A61P9/10;A61P19/08;A61P21/04;A61P25/00;A61P25/16;A61P35/00;C12N5/0775;C12N5/0797 主分类号 C12N15/09
代理机构 代理人
主权项
地址